end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccountsReceivableNetCurrent,AccruedLiabilitiesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,Assets,AssetsCurrent,AssetsNoncurrent,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ContractualObligation,ContractualObligationDueInFifthYear,ContractualObligationDueInFourthYear,ContractualObligationDueInNextTwelveMonths,ContractualObligationDueInSecondYear,ContractualObligationDueInThirdYear,ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear,DebtInstrumentFaceAmount,DebtInstrumentFaceAmount,DebtInstrumentInterestRateStatedPercentage,DebtInstrumentPeriodicPayment,DeferredCreditsAndOtherLiabilitiesCurrent,DeferredFinanceCostsNet,DeferredIncomeCurrent,DeferredOfferingCosts,DefinedBenefitPensionPlanLiabilitiesNoncurrent,DepositsAssetsNoncurrent,Depreciation,DepreciationDepletionAndAmortization,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectOfExchangeRateOnCashAndCashEquivalents,ForeignCurrencyTransactionGainLossBeforeTax,GeneralAndAdministrativeExpense,ImpairmentOfLongLivedAssetsHeldForUse,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeTaxExpenseBenefit,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedTaxesPayable,IncreaseDecreaseInDeferredLiabilities,IncreaseDecreaseInDeposits,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInPensionPlanObligations,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpenseDebt,InterestIncomeExpenseNet,IssuanceOfStockAndWarrantsForServicesOrClaims,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesNoncurrent,LongTermDebtCurrent,LongTermDebtNoncurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAssetsNoncurrent,OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax,OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax,OtherLiabilitiesCurrent,OtherPrepaidExpenseCurrent,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PensionExpenseReversalOfExpenseNoncash,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,PrepaidInsurance,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProfitLoss,PropertyPlantAndEquipmentDisposals,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RestrictedCash,RestrictedCashCurrent,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,Revenues,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,SharesOutstanding,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodValueNewIssues,SubleaseIncome,TaxesPayableCurrent,WarrantsAndRightsOutstanding,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AssetImpairmentCharges,CapitalizedComputerSoftwareAdditions,CapitalizedComputerSoftwareNet,CurrentForeignTaxExpenseBenefit,CurrentIncomeTaxExpenseBenefit,DeferredIncomeTaxesAndOtherTaxReceivableCurrent,DeferredIncomeTaxLiabilities,DeferredTaxAssetsGross,DeferredTaxAssetsOperatingLossCarryforwardsDomestic,DeferredTaxAssetsOperatingLossCarryforwardsForeign,DeferredTaxAssetsOther,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPropertyPlantAndEquipment,DefinedContributionPlanEmployerDiscretionaryContributionAmount,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInOtherCurrentLiabilities,Liabilities,LongTermDebt,LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive,LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo,OperatingLeaseExpense,OperatingLeaseLiability,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFiveYears,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLossCarryforwards,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,OtherReceivablesNetCurrent,ProceedsFromStockOptionsExercised,RepaymentsOfShortTermDebt,StockIssuedDuringPeriodValueStockOptionsExercised,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
2021-03-31,2021-05-10,10-Q,"GAIN THERAPEUTICS,Â INC",GANX,CIK0001819411,USD,881753.0,4486.0,764220.0,16307.0,-156861.0,54104982.0,110725.0,,,48041064.0,47384028.0,657036.0,46593604.0,46636287.0,39132006.0,,,0.0001,50000000.0,11876460.0,11876460.0,1188.0,-2454610.0,2857374.0,271713.0,280448.0,1220177.0,360335.0,297035.0,,,,,,1274752.0,0.0,178418.0,,194465.0,12008.0,3403.0,3403.0,,-0.5,,-19904.0,18539.0,1050675.0,,-2446968.0,3479.0,82927.0,,3456.0,-61065.0,,8075.0,22907.0,,,1408.0,,48041064.0,2326737.0,1250318.0,44287.0,678255.0,41990305.0,-28488.0,-2809907.0,-2450447.0,2472184.0,-2466915.0,121419.0,377598.0,499017.0,37300.0,0.0233,59740.0,-7478.0,-3315.0,1096334.0,66176.0,639693.0,28488.0,,0.0001,10000000.0,0.0,774809.0,641667.0,42629998.0,,,,-2450447.0,0.0,71024.0,54717.0,1421509.0,,11129.0,31554.0,-7034853.0,,5269.0,110725.0,0.0,,44464009.0,,,5269.0,4526.0,,,4868915.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-08-12,10-Q,"GAIN THERAPEUTICS,Â INC",GANX,CIK0001819411,USD,978393.0,353166.0,325079.0,18466.0,-164118.0,54593827.0,191561.0,,344667.0,45353028.0,44335174.0,1017854.0,43162583.0,43204652.0,,,,0.0001,50000000.0,11876460.0,11876460.0,1188.0,-3563950.0,2990970.0,,240389.0,420098.0,278254.0,247083.0,1383768.0,,,,,1218861.0,0.0,370518.0,,235690.0,,,,-0.3,,-0.3,,-44371.0,1810228.0,,-3553033.0,3660.0,,,,,,,,,,5901.0,,45353028.0,2450871.0,1513253.0,65474.0,646661.0,,,,-3556693.0,3603736.0,-3514563.0,181306.0,630902.0,812410.0,,0.0233,,35534.0,42791.0,848343.0,33109.0,,,,0.0001,10000000.0,0.0,808456.0,678175.0,,,,,,,93529.0,75063.0,1793508.0,42069.0,10969.0,31100.0,-7034853.0,81617.0,89173.0,,,,41388904.0,,,7556.0,6837.0,,11876460.0,,11876460.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-12,10-Q,"GAIN THERAPEUTICS,Â INC",GANX,CIK0001819411,USD,789387.0,24713.0,1467253.0,22601.0,-112078.0,55361652.0,250825.0,,517000.0,42562460.0,41554686.0,1007774.0,40979225.0,41014642.0,,,,0.0001,50000000.0,11879743.0,11879743.0,1188.0,-4611493.0,2480844.0,,239851.0,276636.0,250591.0,246576.0,1048834.0,,,,,2520208.0,0.0,327690.0,,243612.0,,,,-0.39,,-0.39,,-27412.0,2186531.0,,-4658419.0,5114.0,,,,,,,,,,4918.0,,42562460.0,3576989.0,1440235.0,86645.0,620167.0,,,,-4663533.0,4663270.0,-4635925.0,170271.0,576456.0,747529.0,,0.0233,,39752.0,-12288.0,2192518.0,185228.0,,,,0.0001,10000000.0,0.0,550748.0,291666.0,,,,,,,125651.0,103050.0,2476739.0,30868.0,,30868.0,-7034853.0,15971.0,27345.0,,,,37545236.0,,,11374.0,10478.0,,11876745.0,,11876745.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
